Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

NEULAND LABORATORIES LTD.

NSE : NEULANDLABBSE : 524558ISIN CODE : INE794A01010Industry : Pharmaceuticals & DrugsHouse : Private

BSE14952.25346.65 (+2.37 %)

PREV CLOSE ( ) 14605.60

OPEN PRICE ( ) 14675.35

BID PRICE (QTY) 14938.10 (7)

OFFER PRICE (QTY) 14974.15 (11)

VOLUME 1964

TODAY'S LOW / HIGH ( )14442.05 15060.90

52 WK LOW / HIGH ( )10060 18089.55

NSE14728.00116 (+0.79 %)

PREV CLOSE( ) 14612.00

OPEN PRICE ( ) 14601.00

BID PRICE (QTY) 14724.00 (3)

OFFER PRICE (QTY) 14736.00 (8)

VOLUME 32254

TODAY'S LOW / HIGH( ) 14450.00 15078.00

52 WK LOW / HIGH ( )10190.7 18100

Quarters

Select year

( in Million)

Particulars

Jun 2025

Mar 2025

Dec 2024

Sep 2024

Audited / UnAudited

UnAudited

Net Sales

2927.53

3283.6

3980.32

3108.44

Total Expenditure

2582.64

2772.87

3114.33

2486.16

PBIDT (Excl OI)

344.89

510.73

865.99

622.28

Other Income

78.56

74.64

39.06

43.32

Operating Profit

423.45

585.37

905.04

665.6

Interest

45.85

23.47

22.17

10.63

Exceptional Items

557.78

PBDT

377.6

561.9

1440.65

654.97

Depreciation

201.9

168.92

163

160.75

Profit Before Tax

175.7

392.98

1277.65

494.22

Tax

36.71

114.93

261.78

165.8

Provisions and contingencies

Profit After Tax

138.99

278.05

1015.87

328.42

Extraordinary Items

Prior Period Expenses

Other Adjustments

Net Profit

138.99

278.05

1015.87

328.42

Minority Interest

Shares of Associates

Other related items

Misc. Expenses Written off

Consolidated Net Profit

139

278.06

1015.87

328.43

Equity Capital

129.01

129

129.01

Face Value (IN RS)

Reserves

Calculated EPS

10.77

21.55

78.74

25.45

Calculated EPS (Annualised)

43.09

86.22

314.99

101.83

No of Public Share Holdings

8637705

8637205

8641675

% of Public Share Holdings

67.32

67.36

PBIDTM% (Excl OI)

11.78

15.55

21.75

20.01

PBIDTM%

14.46

17.82

22.73

21.41

PBDTM%

12.89

17.11

36.19

21.07

PBTM%

6.00

11.96

32.09

15.89

PATM%

4.74

8.46

25.52

10.56

Notes

Risk Disclosures on Derivatives

Quarterly Results

NEULAND LABORATORIES LTD.